Literature DB >> 24394457

Intestinal flora and human health.

T Mitsuoka1.   

Abstract

There is a growing interest in intestinal flora and human health and disease. The intestines of humans contain 100 trillion viable bacteria. These live bacteria, which make up 30% of the faecal mass, are known as the intestinal flora. There are two kinds of bacteria in the intestinal flora, beneficial and harmful. In healthy subjects, they are well balanced and beneficial bacteria dominate. Beneficial bacteria play useful roles in the aspects of nutrition and prevention of disease. They produce essential nutrients such as vitamins and organic acids, which are absorbed from the intestines and utilised by the gut epithelium and by vital organs such as the liver. Organic acids also suppress the growth of pathogens in the intestines.Other intestinal bacteria produce substances that are harmful to the host, such as putrefactive products, toxins and carcinogenic substances. When harmful bacteria dominate in the intestines, essential nutrients are not produced and the level of harmful substances rises. These substances may not have an immediate detrimental effect on the host but they are thought to be contributing factors to ageing, promoting cancer, liver and kidney disease, hypertension and arteriosclerosis, and reduced immunity. Little is known regarding which intestinal bacteria are responsible for these effects. A number of factors can change the balance of intestinal flora in favour of harmful bacteria. These include peristalsis disorders, surgical operations of stomach or small intestine, liver or kidney diseases, pernicious anaemia, cancer, radiation or antibiotic therapies, immune disorders, emotional stress, poor diet and ageing. However, more importantly, the normal balance of intestinal flora may be maintained, or restored to a normal from an unbalanced state, by oral bacterio-therapy or by a well balanced diet. Oral bacterio-therapy using intestinal strains of lactic acid bacteria, such as lactobacillus and bifidobacteria, can restore normal intestinal balance and produce beneficial effects. Benefits include suppression of intestinal putrification so as to reduce constipation and other geriatric diseases; prevention and treatment of diarrhoea including antibiotic-associated diarrhoea; stimulation of the immune system; and increased resistance to infection.

Entities:  

Year:  1996        PMID: 24394457

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  17 in total

Review 1.  The acetate switch.

Authors:  Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

2.  Mining bifidobacteria from the neonatal gastrointestinal tract for conjugated linolenic acid production.

Authors:  Bo Yang; Haiqin Chen; Catherine Stanton; Yong Q Chen; Hao Zhang; Wei Chen
Journal:  Bioengineered       Date:  2016-09-22       Impact factor: 3.269

3.  Effect of Whole-Grain Barley on the Human Fecal Microbiota and Metabolome.

Authors:  Maria De Angelis; Eustacchio Montemurno; Lucia Vannini; Carmela Cosola; Noemi Cavallo; Giorgia Gozzi; Valentina Maranzano; Raffaella Di Cagno; Marco Gobbetti; Loreto Gesualdo
Journal:  Appl Environ Microbiol       Date:  2015-09-18       Impact factor: 4.792

4.  Mining the microbiota of the neonatal gastrointestinal tract for conjugated linoleic acid-producing bifidobacteria.

Authors:  E Rosberg-Cody; R P Ross; S Hussey; C A Ryan; B P Murphy; G F Fitzgerald; R Devery; C Stanton
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

Review 5.  The Role of Microbiota in Infant Health: From Early Life to Adulthood.

Authors:  Yao Yao; Xiaoyu Cai; Yiqing Ye; Fengmei Wang; Fengying Chen; Caihong Zheng
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

Review 6.  Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis.

Authors:  Kuniaki Terato; Christopher T Do; Hiroshi Shionoya
Journal:  Autoimmune Dis       Date:  2015-03-12

7.  Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.

Authors:  Janice Crespo-Salgado; V Matti Vehaskari; Tyrus Stewart; Michael Ferris; Qiang Zhang; Guangdi Wang; Eugene E Blanchard; Christopher M Taylor; Mahmoud Kallash; Larry A Greenbaum; Diego H Aviles
Journal:  Microbiome       Date:  2016-09-17       Impact factor: 14.650

8.  Fatty acid composition and phospholipid types used in infant formulas modifies the establishment of human gut bacteria in germ-free mice.

Authors:  Rikke Guldhammer Nejrup; Tine Rask Licht; Lars Ingvar Hellgren
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

9.  Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.

Authors:  Satoru Hasegawa; Sae Goto; Hirokazu Tsuji; Tatsuya Okuno; Takashi Asahara; Koji Nomoto; Akihide Shibata; Yoshiro Fujisawa; Tomomi Minato; Akira Okamoto; Kinji Ohno; Masaaki Hirayama
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

10.  Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students.

Authors:  Naoko Mori; Mitsuyoshi Kano; Norie Masuoka; Tomoe Konno; Yumiko Suzuki; Kouji Miyazaki; Yukihide Ueki
Journal:  Biosci Microbiota Food Health       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.